September 28, 2022: I want to comment very briefly on the PFAS recommendations, since that’s an issue we’ve worked on for years. Let me add that we are very concerned about all endocrine disrupting chemicals not just PFAS.
Read More »Author: Caroline Bradford
Testimony of Dr. Diana Zuckerman About PEPAXTO FDA Advisory Committee Meeting on September 22, 2022
We testified before the FDA Advisory Committee that Pepaxto should no longer be approved for multiple myeloma because new research shows that patients taking it died 5 months sooner than patients taking a different treatment.
Read More »NCHR Letter to Sen. Smith in Support of Women’s Health Legislation
September 22, 2022: Two bills led by Sen. Smith take critical steps to help protect access to safe and effective reproductive health care products. We at NCHR are appreciative of her work to act in the face of the many challenges presented following the Dobbs decision.
Read More »What You Need to Know About Preventing and Treating Monkeypox (Mpox)
Monkeypox can infect anyone. It is important to know how to protect yourself and your family. Here is information symptoms, how to prevent infection, vaccines and treatments, and the research showing they are safe and effective.
Read More »NCHR Comments on the CMS National Coverage Analysis of Seat Extenders for Wheelchairs
September 14, 2022: We strongly support the coverage of wheelchair seat extender systems through Medicare and encourage CMS quickly act on this decision. There are numerous direct medical benefits from the use of power seat elevation systems in power wheelchairs. Many preventable complications and secondary conditions are common among individuals who spend long periods of time unable to stand or walk, restricted to a bed, chair, or wheelchair.
Read More »